
18.00 Delayed Data As of 4:00pm ET | ![]() Today’s Change | 10.48 Today|||52-Week Range 19.59 | +10.36% Year-to-Date |
The 8 analysts offering 12-month price forecasts for Chinook Therapeutics Inc have a median target of 31.50, with a high estimate of 48.00 and a low estimate of 28.00. The median estimate represents a +75.00% increase from the last price of 18.00.
The current consensus among 9 polled investment analysts is to Buy stock in Chinook Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.